In a series of in vitro experiments with AML cell lines, we showed that Cytarabine or Decitabine, CTs commonly used for AML, significantly enhanced expression of HMGCR in CT-treated cells and increased cholesterol levels as well as sEV release from these cells. The gene discussed is HMGCR; the disease is acute myeloid leukemia.